Evidence map›Paper›PMID 29619064›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

A Traditional Herbal Formula Xianlinggubao for Pain Control and Function Improvement in Patients with Knee and Hand Osteoarthritis: A Multicenter, Randomized, Open-Label, Controlled Trial.

Fei Wang, Lei Shi, Yaonan Zhang, Kunzheng Wang, Fuxing Pei, Hanmin Zhu, Zhanjun Shi, Tianzun Tao, Zhihua Li, Ping Zeng and 4 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04395547 (A Randomized, Double-blind, Placebo-controlled, Parallel Study to Investigate the Safety and Efficacy of JointAlive™ on Improving Knee Joint Function in Adults With Mild to Moderate Knee Osteoarthritis), which is not on this map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04395547 nacompletednot on this mapstarted 2020, after this paper: background citation

A Randomized, Double-blind, Placebo-controlled, Parallel Study to Investigate the Safety and Efficacy of JointAlive™ on Improving Knee Joint Function in Adults With Mild to Moderate Knee Osteoarthritis

TypeinterventionalSponsorChenland Nutritionals Inc.Ran2020 to 2022Enrolled72ConditionsOsteo Arthritis KneeArmsJointAlive™, Placebo
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 8 institutions in 2 countries.

Fei WangDepartment of Orthopedics, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.ORCID 0000-0002-7155-1024
Lei ShiDepartment of Orthopedics, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Yaonan ZhangDepartment of Orthopedics, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Kunzheng WangDepartment of Orthopedics, The Second Affiliated Hospital, Medical School of Xi'an Jiaotong University, Xi'an 710004, China.ORCID 0000-0002-1981-4237
Fuxing PeiDepartment of Orthopaedics, First University Hospital, West China University of Medical Sciences, Chengdu 610041, China.
Hanmin ZhuDepartment of Osteoporosis, The Affiliated Huadong Hospital of Fudan University, Research Unit of Elderly Bone Metabolic Disease of Shanghai Geriatrics Institute, Shanghai 200040, China.
Zhanjun ShiDepartment of Orthopaedics, Southern Medical University, Nanfang Hospital, Guangzhou 510515, China.
Tianzun TaoSecond Department of Orthopaedic Surgery, The Affiliated Second Hospital of Harbin Medical University, Harbin 150086, China.
Zhihua LiInstitute of Integrative Medicine, Hebei Medical University, Shijiazhuang 050017, China.
Ping ZengBeijing Institute of Geriatric Diseases, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Xiaobing WangDepartment of Orthopedics, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Quan JiDepartment of Orthopedics, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.
Ling QinDepartment of Orthopaedics & Traumatology, The Chinese University of Hong Kong, Shatin 200433, Hong Kong.
Qingxun XueDepartment of Orthopedics, Beijing Hospital, National Center of Gerontology, Beijing 100730, China.ORCID 0000-0001-5880-9177
Beijing Hospital · CNChinese University of Hong Kong · HKFudan University · CNHarbin Medical University · CNHebei Medical University · CNNanfang Hospital · CNSecond Affiliated Hospital of Xi'an Jiaotong University · CNWest China Medical Center of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evidence of efficacy of a traditional herbal formula Xianlinggubao (XLGB) for treatment of osteoarthritis (OA) is limited. The present study was designed to evaluate the efficacy of XLGB in the management of patients with knee and hand OA. This was a multicenter, stratified, open-label, randomized controlled trial conducted at six centers in China. People aged 40 or above, diagnosed with OA of the knee or hand, were randomly assigned to the XLGB treatment group or watchful waiting control group. Main outcome measures were the changes in the numeric pain rating scales (NPRS) and the Western Ontario and McMaster Universities Arthritis Index (WOMAC) or the Australian/Canadian Osteoarthritis Hand Index (AUSCAN) scores, from baseline to 6 months. In total 534 patients (272 to XLGB and 262 to control group) received interventions. Participants in the XLGB group exhibited significant improvement in NPRS (

Identifiers

PMID29619064
PMCPMC5829359
OpenAlexW2792098893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.